Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells.

Source:http://linkedlifedata.com/resource/pubmed/id/19530242

Int. J. Cancer 2009 Nov 1 125 9 2004-13

Download in:

View as

Triples

General Info

PMID
19530242